Astellas/Pfizer Settle Dispute Over Lipitor Rights In Japan

Firms also gain Japanese marketing approval for celecoxib for treatment of inflammation and pain associated with rheumatoid arthritis and osteoarthritis.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Japan

More from Asia